Analysed Hepion Pharmaceuticals Inc (HEPA:OTCMKTS) News Sources
Hepion Pharmaceuticals In-Licenses ctRNA Biomarker Assay to Facilitate Early Diagnosis and Surveillance of Hepatocellular Carcinoma
Yahoo Finance
Hepion Pharmaceuticals, Inc.: Hepion Pharmaceuticals In-Licenses ctRNA Biomarker Assay to Facilitate Early Diagnosis and Surveillance of Hepatocellular Carcinoma
FinanzNachrichten.de
Hepion Further Cements Shift From Therapeutics to Diagnostics With ctRNA Licensing Deal
Precision Medicine Online
What is the current price of Hepion Pharmaceuticals Inc (HEPA:OTCMKTS)?
The current price of Hepion Pharmaceuticals Inc (HEPA:OTCMKTS) is $0.042.
Hepion Pharmaceuticals Inc (HEPA:OTCMKTS) absolute price change since previous trading day?
The absolute price change of Hepion Pharmaceuticals Inc (HEPA:OTCMKTS) since the previous trading day is $-0.00.
Hepion Pharmaceuticals Inc (HEPA:OTCMKTS) percentage price change since previous trading day?
The percentage price change of Hepion Pharmaceuticals Inc (HEPA:OTCMKTS) since the previous trading day is -2.33%.
What is This Week's average sentiment score for Hepion Pharmaceuticals Inc (HEPA:OTCMKTS)?
This Week's average sentiment score for Hepion Pharmaceuticals Inc (HEPA:OTCMKTS) is 88 out of 100.
What is This Week's average sentiment for Hepion Pharmaceuticals Inc (HEPA:OTCMKTS)?
This Week's sentiment for Hepion Pharmaceuticals Inc (HEPA:OTCMKTS) is .
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.